Open AccessConcurrent PIK3CA mutation: A cause for primary resistance to epidermal growth factor receptor tyrosine kinase inhibitors or an acquired phenomenon?
Author(s) -
Amit Kumar Verma,
Umut Dişel,
Jatinder Kaur
Publication year - 2021
Publication title -
cancer research, statistics, and treatment/cancer research, statistics and treatment
Language(s) - English
Resource type - Journals
eISSN - 2590-3233
pISSN - 2590-3225
DOI - 10.4103/crst.crst_256_21
Subject(s) - mutation , tyrosine kinase , acquired resistance , epidermal growth factor receptor , cancer research , biology , receptor , genetics , drug resistance , gene